SCPH
scPharmaceuticals Inc
Halal Rating :
Last Price
$3.27
Last updated:
Market Cap
-
7D Change
-6.84%
1 Year Change
-40.76%
Company Overview
Industries
Exchange
Next Earnings Date
scPharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing products that can be administered at home via subcutaneous delivery. Their lead product is FUROSCIX®, which is designed for the treatment of congestion in patients with heart failure. The company aims to reduce healthcare costs and improve patient care by enabling self-administered treatments that would traditionally require hospitalization.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $10.03m | $43.05m | - | $14.88m | 0.00% | 34.57% |
| June 30, 2024 | $8.05m | $24.62m | - | $2.13m | 0.00% | 8.67% |
| March 31, 2024 | $6.1m | $24.06m | - | $2.1m | 0.00% | 8.73% |
Company Impact
Help us evaluate scPharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.